drugset / Trial / NCT03348098
Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of apatinib in patient with TNBC
Timeline
- Start
- 2017-09-06
- Primary completion
- 2018-07-06
- Completion
- 2018-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | — |